Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V H Bono

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cancer Chemotherapy Reports|May 1, 1975
L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamineH N Jayaram, D A Cooney, J A Ryan, et al.
Bibliotheca Haematologica|October 1, 1975
Experimental studies with maytansine--a new antitumor agentS M Sieber, M K Wolpert, R H Adamson, et al.
Cancer Treatment Reports|November 1, 1979
Analysis and interpretation of response rates for anticancer drugsY J Lee, R Catane, M Rozencweig, et al.
Biochemical Pharmacology|June 15, 1979
Surface alterations of P388 leukemia cells by 2-deoxy-D-glucoseM W Myers-Robfogel, Z N Canellakis, V H Bono, et al.
Cancer Treatment Reports|January 1, 1980
Phase II trials: use of a clinical tumor panel and overview of current resources and studiesF M Muggia, M Rozencweig, D F Chiuten, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cancer Chemotherapy Reports|May 1, 1975
L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamineH N Jayaram, D A Cooney, J A Ryan, et al.
Bibliotheca Haematologica|October 1, 1975
Experimental studies with maytansine--a new antitumor agentS M Sieber, M K Wolpert, R H Adamson, et al.
Cancer Treatment Reports|November 1, 1979
Analysis and interpretation of response rates for anticancer drugsY J Lee, R Catane, M Rozencweig, et al.
Biochemical Pharmacology|June 15, 1979
Surface alterations of P388 leukemia cells by 2-deoxy-D-glucoseM W Myers-Robfogel, Z N Canellakis, V H Bono, et al.
Cancer Treatment Reports|January 1, 1980
Phase II trials: use of a clinical tumor panel and overview of current resources and studiesF M Muggia, M Rozencweig, D F Chiuten, et al.
Pageof 3